Diagnostic and prognostic value of SHOX2 and SEPT9 DNA methylation and cytology in benign, paramalignant, and malignant ascites
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Diagnostic and prognostic value of SHOX2 and SEPT9 DNA methylation and cytology in benign, paramalignant, and malignant ascites
Authors
Keywords
DNA methylation, Biomarkers, Ascites, Liquid biopsy, Cancer diagnosis, Cytology, Cell-free DNA, <em class=EmphasisTypeItalic >SHOX2</em>, <em class=EmphasisTypeItalic >SEPT9</em>
Journal
Clinical Epigenetics
Volume 8, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-03-01
DOI
10.1186/s13148-016-0192-7
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Circulating free DNA concentration is an independent prognostic biomarker in lung cancer
- (2015) Claire Tissot et al. EUROPEAN RESPIRATORY JOURNAL
- Circulating cell-free DNA in serum as a biomarker for diagnosis and prognostic prediction of colorectal cancer
- (2014) T B Hao et al. BRITISH JOURNAL OF CANCER
- Circulating cell-free DNA as a promising biomarker in patients with gastric cancer: diagnostic validity and significant reduction of cfDNA after surgical resection
- (2014) Kyongchol Kim et al. Annals of Surgical Treatment and Research
- Interplay between the Cancer Genome and Epigenome
- (2013) Hui Shen et al. CELL
- Prospective evaluation of methylatedSEPT9in plasma for detection of asymptomatic colorectal cancer
- (2013) Timothy Robert Church et al. GUT
- Staging classification for cancer of the ovary, fallopian tube, and peritoneum
- (2013) Jaime Prat et al. INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS
- Prevalence of Prostate Cancer on Autopsy: Cross-Sectional Study on Unscreened Caucasian and Asian Men
- (2013) Alexandre R. Zlotta et al. JNCI-Journal of the National Cancer Institute
- Diagnostic and Prognostic Value of SHOX2 and SEPT9 DNA Methylation and Cytology in Benign, Paramalignant and Malignant Pleural Effusions
- (2013) Dimo Dietrich et al. PLoS One
- Epigenetic Reprogramming in Cancer
- (2013) M. L. Suva et al. SCIENCE
- DNA Methylation of the Homeobox Genes PITX2 and SHOX2 Predicts Outcome in Non–small-cell Lung Cancer Patients
- (2012) Dimo Dietrich et al. DIAGNOSTIC MOLECULAR PATHOLOGY
- Functions of DNA methylation: islands, start sites, gene bodies and beyond
- (2012) Peter A. Jones NATURE REVIEWS GENETICS
- Correlation of SHOX2 Gene Amplification and DNA Methylation in Lung Cancer Tumors
- (2011) Katja U Schneider et al. BMC CANCER
- SHOX2 DNA Methylation Is a Biomarker for the Diagnosis of Lung Cancer in Plasma
- (2011) Christoph Kneip et al. Journal of Thoracic Oncology
- Circulating DNA is a Useful Prognostic Factor in Patients with Advanced Non-small Cell Lung Cancer
- (2011) Rafael Sirera et al. Journal of Thoracic Oncology
- SHOX2 DNA Methylation is a Biomarker for the diagnosis of lung cancer based on bronchial aspirates
- (2010) Bernd Schmidt et al. BMC CANCER
- Performance of Epigenetic Markers SEPT9 and ALX4 in Plasma for Detection of Colorectal Precancerous Lesions
- (2010) Marc Tänzer et al. PLoS One
- Circulating mitochondrial DNA in serum: A universal diagnostic biomarker for patients with urological malignancies
- (2010) Jörg Ellinger et al. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS
- Circulating Methylated SEPT9 DNA in Plasma Is a Biomarker for Colorectal Cancer
- (2009) T. deVos et al. CLINICAL CHEMISTRY
- Sensitive Detection of Colorectal Cancer in Peripheral Blood by Septin 9 DNA Methylation Assay
- (2008) Robert Grützmann et al. PLoS One
- DNA Methylation Biomarkers for Blood-Based Colorectal Cancer Screening
- (2007) C. Lofton-Day et al. CLINICAL CHEMISTRY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now